Dexcom | DXCM - Zinsaufwendungen Für Schuld

Aktienkurs
59.57
Täglich Wechseln
2.01 3.49%
Monatlich
-5.14%
Jährlich
-15.21%
Q2 Prognose
60.25




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
J&J USD 43M 25M 2026-03
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 607M 450M 2025-12
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
West Pharmaceutical Services USD 1.9M 1.7M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03